Browse By: Country ι Category ι Publisher ι Tag

The World Pharmaceutical Markets Fact Book 2013

Pages » N/A
Published By » Espicom
Price » $1545
In stock
View Report Details
Description

The indispensable source of thousands of facts, figures and statistics for 67 pharmaceutical markets worldwide! The World Pharmaceutical Market Fact Book 2013 is the ideal companion in today’s challenging pharmaceutical market environment. The need to understand world pharmaceutical marketplaces, and be able to answer quickly those questions that arise daily, is essential. That is why this current and comprehensive source of key market statistics is an invaluable aid for every pharmaceutical industry executive. Proven and reliable Published by Espicom - experts in the healthcare field for over 30 years, the Fact Book brings together a range of often difficult to source infor... Click here for more details


Breast Cancer Drug Discoveries: What the Future Holds
In 2010, almost 50% of breast cancer sales were due to three branded targeted therapies. With a large unmet clinical need, further agents are required to increase survival and delay disease progression. Unique breast cancer market share, sales forecasts by launched and Phase III products to 2
Published Date: Aug 2011
Price: $3145
The Outlook for Pharmaceuticals in Brazil, Russia, India & China
These leading emerging economies represent a combined pharmaceutical market of US$132.2 billion. How have they emerged from the economic downturn? Where do commercial opportunities exist for pharmaceutical companies over the 2011-16 forecast period? Putting things in perspective...
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in Central Asia
These reports analyse the issues These reports provide a detailed analysis of four of the most populous countries in the world and the massive potential of their pharmaceutical markets. The markets of Central Asia contrast well; China and India are two of the largest pharmaceutical markets with ver
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in Central & Eastern Europe
The pharmaceutical market of Central & Eastern Europe is estimated at US$63.6 billion at retail prices in 2011; it is expected to reach US$104.2 billion by 2016. The market is expected to expand by a moderate CAGR in US dollar terms between 2011 and 2016, as the region’s economies reco
Published Date: Feb 2012
Price: $3630
E7: The Outlook for Pharmaceuticals to 2012
The E7 economies represent increasing opportunities for pharmaceutical companies constrained by maturing markets in the west. Huge potential in E7 markets The emerging E7 countries represent the best prospect for growth. The potential of these countries is huge: they have a combined
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in Latin America
Strong pharmaceutical market growth opportunities and regulatory developments are making Latin America more attractive The region needs to increase drug access, despite intensifying cost-containment measures. Therefore, attractive opportunities for (bio)pharmaceutical producers exist in Latin A
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in the Middle East and North Africa
Macro-environmental conditions affected by political unrest In spite of recent political unrest, economic, social and demographic changes are making the pharmaceutical markets in the Middle East & North Africa (MENA) region more attractive. The Economist Intelligence Unit (EIU) forecasts th
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in Northern Europe
The Northern European countries are projected to represent a combined pharmaceutical market value of over US$23 billion at retail prices by 2016. The seven Northern European pharmaceutical markets are diverse, from the stable well-developed markets of Scandinavia to the less well-funded
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in South East Asia
The eight pharmaceutical markets of South East Asia are developing at markedly different speeds and are characterised by contrasting macroeconomic factors. These markets are projected to have a combined pharmaceutical market value of US$69.1 billion at retail prices in 2016. Established&hel
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in Western Europe
Market growth in the mature markets of Western Europe is assured over the coming years by the health needs of ageing populations, and will be driven by investment in innovative medicines, particularly in the hospital market. Growth, however, will be tempered somewhat by the effects of the glob
Published Date: Feb 2012
Price: $3630

 


 

Related News

China’s Huawei to Setup 4G Network in Cambodia
EMAXX, the Cambodian telecommunications company has signed a deal with the Chinese Huawei on Wednesday to build and develop a 4G network in Cambodia. The contract was signed by Ai Minn, the CEO of EMAXX, and the DGM of Huawei Technologies Weng Kefeng. The signing was performed in the presence of the Chinese Embassy’s Cambodian political councilor Li Zhigong and Kan Channmeta, Secretary of State at the Cambodian Ministry of Posts and Telecom. The contract states that Huawei will build
Date: Sep 18

Cost Watchdog of Britain’s Healthcare Sector Approves GSK’s Melanoma Drug under Price-Cut Conditions
Cost control agency of Britain’s healthcare sector, The National Institute for Health and Care Excellence (NICE), has recommended a drug for melanoma marketed by GlaxoSmithKline after the drug maker offered to supply it at a discounted rate to the National Health Service.  The drug, titled Tafinlar, is currently marketed by GSK but it will soon be transferred to Novartis under a trade deal between the tow companies.  Tafinlar is an oral drug that works in a way similar to R
Date: Sep 18

Weakening Rouble Makes GM Cut Production and Cut Jobs in Russia
Opel Group, the European subsidiary of general Motors has planned to cut production and shed nearly 500 jobs in Russia. The decision comes ahead of the weakening Russian rouble and the drop in local demand due to slow economic growth and Western sanctions. Opel stated that it would cut production from two shifts per day to one, at its St. Petersburg plant where it produces Chevrolet Cruze compact and Opel Astra. The company will also offer voluntary severance letters to nearly 500 of the p
Date: Sep 17

Only 44% Americans Think College Education “Very Important”: Poll
A recent annual poll has revealed some shocking statistics regarding Americans’ views on the need for a college education. The poll showed that only 44% of Americans believed that a college education was “very important”, a drastic drop from 75% just four years ago. The 46th annual PDK-Gallup poll also found that most parents of kids in public schools wish that teacher training programs be more selective and that new teachers work under a certified teacher for at least a yea
Date: Sep 17

Fashion Industry Embraces Technology at London Fashion Week
The London Fashion Week cast the spotlight this week not just on the clothes on the runway, but the technology that surrounded the event. In what could be termed as a new digital first for the fashion industry, Burberry teamed up with Twitter to launch the new click-to-buy button to people across the globe. The British luxury fashion house made its nail paint that will be showcased at the LFW available to Twitterati. The social media website is currently trying out the “buy now” feat
Date: Sep 16

Bitcoin Mining Firm Free from Cease Trade
A Saskatchewan based Dominion Bitcoin Mining Company is now free from cease trade and is operating once again.  The cease-trade order against Bitcoin was lifted in May by the Financial and Consumer Affairs Authority (FCAA) with no penalty being issued after it expired last week.  FCAA’s action toward originally issuing the order was because it believed the mining firm had been looking out for various investors in the Saskatchewan region without actually being registered to
Date: Sep 16

Hawaii Earns a “C” in the Blue Planet Foundation’s 2014 Energy Report Card
According to a report published by Blue Planet Foundation, Hawaii received an “average” grade for its clean energy progress. The Blue Planet Foundation’s 2014 Energy Report Card for Hawaii has shown a slight improvement since 2013 which was at “C-minus”. This year the report card has improved to “C”. The report is a 42-page document which gives a broad perspective of Hawaii’s energy transformation. It overlooks key aspects such as transportation
Date: Sep 16

Coke’s Surge to be Reintroduced in the Global Beverages Market
A flavored drink that was discontinued more than a decade ago by Coca Cola, has again been brought back in the beverages market. This citrus flavored drink called Surge is a Mountain Dew knockoff. This drink is only available at Amazon.com. This happens to be Coca Cola’s first ever e-commerce reintroduction. The reintroduction of Surge has been announced at the “Surge Movement” which is a Facebook Fan site.  The members of this fan site are excited about the return of t
Date: Sep 16

Cipla Rises by 10% in Two Days
In a relatively weaker market, Cipla has managed to rally stocks by 3% up to $10.34, a record high for the pharmaceutical company in the National Stock Exchange (NSE). The latest rally brings the stock for Cipla up by nearly 10% within a span of two days. The stocks rose from a previous $9.46 two days ago. The growth added some relief to a CNX Nifty market that was declining by 1%. The stocks started gaining ground after Cipla launched their anti-asthma inhalers in Germany and Sweden. The
Date: Sep 15

Target for Automotive Mission Plan 2016 to Fall Short by 25%
India is likely to miss the ambitious target it had set for Automotive Mission Plan (AMP) 2016 as the country suffered an economic slowdown in the last three years. The lingering effect of the economic downturn will hit the target with a negative 25%.  The target was set at $145 billion for AMP 2006-2016 with special focus on export of small cars, two and three wheelers, auto components, and MUVs. The review of AMP 2006-2016 shows, growth rate so far will not be enough to meet the target
Date: Sep 15

Upcoming Reports

Acute Myeloid Leukemia (AML) Therapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, imma
Published By: Transparency Market Research
Price: $4795
Antibiotic Market - Global Industry Size, Share, Trends, Analysis And Forecast, 2012 - 2018
An antibiotic is a compound or a substance that fights bacterial infections and kills or slow down their growth. The antibiotic market is witnessing high growth due new product innovations and higher investment in R & D activity. Moreover, the other regulatory concerns to control the antibioti
Published By: Transparency Market Research
Price: $4795
Next Generation Sequencers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Next generation sequencers are used inthe sequencing technologies which massively parallelize the DNA sequencing process rather than being limited to single or few fragments of DNA. The next generation sequencing (NGS) technology enables rapid sequencing and produce thousands and millions of seque
Published By: Transparency Market Research
Price: $4795
Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal
Published By: Transparency Market Research
Price: $4795
Prenatal Diagnostics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Prenatal diagnostics is a procedure for testing of diseases before the birth of a child, to determine certain inheritable disorders such as chromosome abnormalities, Down’s syndrome, genetic diseases, neural tube defects, and other conditions. It can be conducted by various procedures of scr
Published By: Transparency Market Research
Price: $4795
Pediatric Vaccines Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those i
Published By: Transparency Market Research
Price: $4795
Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatolog
Published By: Transparency Market Research
Price: $4795
Hepatitis C Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The world market for HCV drugs represents an area of potential opportunities in developed as well as developing countries. Because of the technological advancements and effectiveness, many big market players are focusing on development of innovative drugs for HCV. Major companies are forming coali
Published By: Transparency Market Research
Price: $4795
EPharmacies Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
The global market for ePharmacies is projected to reach USD 51.75 billion by the end of 2017 owing to the increasing number of tech-savvy people and rising demand for prescription drugs. The ePharmacies meeting the regulatory standards set by the government and following ethical business practices
Published By: Transparency Market Research
Price: $4795
Congestive Heart Failure Treatment Devices Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The global market for congestive heart failure treatment devices is expected to reach $5.9 billion by the year 2016 at the compounded annual growth rate of 11.7% during the forecasted period. This growth is mainly attributed by the rising incidences of heart failures across the world. American mar
Published By: Transparency Market Research
Price: $4795